Literature DB >> 22843548

Independent genetic control of early and late stages of chemically induced skin tumors in a cross of a Japanese wild-derived inbred mouse strain, MSM/Ms.

Kazuhiro Okumura1, Miho Sato, Megumi Saito, Ikuo Miura, Shigeharu Wakana, Jian-Hua Mao, Yuki Miyasaka, Ryo Kominami, Yuichi Wakabayashi.   

Abstract

MSM/Ms is an inbred mouse strain derived from a Japanese wild mouse, Mus musculus molossinus. In this study, we showed that MSM/Ms mice exhibit dominant resistance when crossed with susceptible FVB/N mice and subjected to the two-stage skin carcinogenesis protocol using 7,12-dimethylbenz(a)anthracene (DMBA)/ 12-O-tetradecanoylphorbol-13-acetate (TPA). A series of F1 backcross mice were generated by crossing p53(+/+) or p53(+/-) F1 (FVB/N × MSM/Ms) males with FVB/N female mice. These generated 228 backcross animals, approximately half of which were p53(+/-), enabling us to search for p53-dependent skin tumor modifier genes. Highly significant linkage for papilloma multiplicity was found on chromosomes 6 and 7 and suggestive linkage was found on chromosomes 3, 5 and 12. Furthermore, in order to identify stage-dependent linkage loci we classified tumors into three categories (<2mm, 2-6mm and >6mm), and did linkage analysis. The same locus on chromosome 7 showed strong linkage in groups with <2mm or 2-6mm papillomas. No linkage was detected on chromosome 7 to papillomas >6mm, but a different locus on chromosome 4 showed strong linkage both to papillomas >6mm and to carcinomas. This locus, which maps near the Cdkn2a/p19(Arf) gene, was entirely p53-dependent, and was not seen in p53 (+/-) backcross animals. Suggestive linkage conferring susceptibility to carcinoma was also found on chromosome 5. These results clearly suggest distinct loci regulate each stage of tumorigenesis, some of which are p53-dependent.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22843548     DOI: 10.1093/carcin/bgs250

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

1.  Variants in an Hdac9 intronic enhancer plasmid impact Twist1 expression in vitro.

Authors:  Tyler E Siekmann; Madelyn M Gerber; Amanda Ewart Toland
Journal:  Mamm Genome       Date:  2015-12-31       Impact factor: 2.957

2.  Mapping of new skin tumor susceptibility loci by a phenotype-driven congenic approach.

Authors:  Kyoko Fujiwara; Yoshinori Inagaki; Masayoshi Soma; Toshinori Ozaki; Hiroki Nagase
Journal:  Oncol Lett       Date:  2018-09-24       Impact factor: 2.967

3.  Time-Series Analysis of Tumorigenesis in a Murine Skin Carcinogenesis Model.

Authors:  Yoshimasa Aoto; Kazuhiro Okumura; Tsuyoshi Hachiya; Sumitaka Hase; Yuichi Wakabayashi; Fuyuki Ishikawa; Yasubumi Sakakibara
Journal:  Sci Rep       Date:  2018-08-29       Impact factor: 4.379

4.  Congenic mapping and allele-specific alteration analysis of Stmm1 locus conferring resistance to early-stage chemically induced skin papillomas.

Authors:  Kazuhiro Okumura; Megumi Saito; Eriko Isogai; Ikuo Miura; Shigeharu Wakana; Ryo Kominami; Yuichi Wakabayashi
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

5.  Meis1 regulates epidermal stem cells and is required for skin tumorigenesis.

Authors:  Kazuhiro Okumura; Megumi Saito; Eriko Isogai; Yoshimasa Aoto; Tsuyoshi Hachiya; Yasubumi Sakakibara; Yoshinori Katsuragi; Satoshi Hirose; Ryo Kominami; Ryo Goitsuka; Takuro Nakamura; Yuichi Wakabayashi
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

6.  Identification of Stmm3 locus conferring resistance to late-stage chemically induced skin papillomas on mouse chromosome 4 by congenic mapping and allele-specific alteration analysis.

Authors:  Megumi Saito; Kazuhiro Okumura; Ikuo Miura; Shigeharu Wakana; Ryo Kominami; Yuichi Wakabayashi
Journal:  Exp Anim       Date:  2014

7.  The parathyroid hormone regulates skin tumour susceptibility in mice.

Authors:  Kazuhiro Okumura; Megumi Saito; Yasuhiro Yoshizawa; Haruka Munakata; Eriko Isogai; Ikuo Miura; Shigeharu Wakana; Midori Yamaguchi; Hiroshi Shitara; Choji Taya; Andrew C Karaplis; Ryo Kominami; Yuichi Wakabayashi
Journal:  Sci Rep       Date:  2017-09-11       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.